comparemela.com

Latest Breaking News On - Preclinical therapeutics program - Page 1 : comparemela.com

Latest study could help future therapies to sway COVID-19 virus

Latest study could help future therapies to sway COVID-19 virus ANI | Updated: Dec 13, 2020 17:08 IST Washington [US], December 13 (ANI): Study published in the journal cell online revealed that by targeting a single protein cell which appears essential for SARS-CoV-2 to replicate could control the spread of the virus. The latest finding from a pair of studies led by researchers at NYU Grossman School of Medicine and NYU Langone Health s Perlmutter Cancer Center and colleagues at Rockefeller University revealed that a protein named TMEM41B is necessary for the COVID-19virus to reproduce and spread to other cells and hence is a potential weakness that could be targeted by future therapies.

Washington
United-states
Nile
Johnt-poirier
Langone-health
Grossman-school-of-medicine
Rockefeller-university
Preclinical-therapeutics-program
Langone-health-perlmutter-cancer-center
Perlmutter-cancer-center
West-nile

Studies reveal potential weaknesses in SARS-CoV-2 infection — Agenparl

Studies reveal potential weaknesses in SARS-CoV-2 infection — Agenparl
agenparl.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from agenparl.eu Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Memorial-sloan-kettering-cancer-center
Nile
Rockefeller-university
Eliana-jacobson
Joseph-luna
Linda-miles
Scott-lowe
Johnt-poirier
Alison-ashbrook
Xianfang-wu

Studies reveal potential weaknesses in SARS-CoV-2 infection

Studies reveal potential weaknesses in SARS-CoV-2 infection
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

United-states
Washington
Nile
Johnt-poirier
Langone-health
Grossman-school-of-medicine
Rockefeller-university
Preclinical-therapeutics-program
Langone-health-perlmutter-cancer-center
Perlmutter-cancer-center
West-nile

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies. The molecule, known as transmembrane protein 41 B (TMEM41B), is believed to help shape the fatty outer membrane that protects the virus genetic material while it replicates inside an infected cell and before it infects another. The latest finding comes from a pair of studies led by researchers at NYU Grossman School of Medicine and NYU Langone Health s Perlmutter Cancer Center, and colleagues at Rockefeller University and elsewhere.

United-states
Johnt-poirier
Emily-henderson
Langone-health
School-of-medicine
Preclinical-therapeutics-program
Langone-health-perlmutter-cancer-center
Grossman-school-of-medicine
Rockefeller-university
Perlmutter-cancer-center
West-nile
Co-senior-investigator

vimarsana © 2020. All Rights Reserved.